Fundamental Analysis of Bioventus Inc - Growth / Value Index
BVS - Valuation Highlights
Valuation Analysis
Book Value in last 3 years is trending up
Tsr Value Index - Poor Score of 32.81
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 16.60 | 39.35 | 327.88 % | |
| Price to Book | 3.94 | 3.92 | -14.33 % | 3.31 |
| Price to Sales | 1.55 | 1.57 | 6.41 % | |
| Enterprise Value to EBITDA Multiple | 14.65 | 10.81 | 146.91 % |
BVS - Profitability Highlights
Profitability Analysis
Tsr Profitability Index - Good Score of 65.62
Piotroski F Score - Good Value of 7.0
Net profit has jumped from negative to positive
Excellent QoQ /QoQ FY EPS growth
During the past twelve months, the company has given a strong Return On Equity of 29.32%
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Steady Growth in EPS for last four quarters
Very Low Dividend Yield of 0 %
Low Earning Yield of 5.99 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 29.32 | 12.35 | 137.18 % | 14.65 |
| Return On Asset | 7.97 | 3.33 | 149.28 % | 4.97 |
| Net Profit Margin | 9.36 | 4.00 | 146.70 % | 21.83 |
| Operating Profit Margin | 10.66 | 10.31 | 126.88 % | 12.48 |
| EBITDA Margin | 13.30 | 18.58 | 314.96 % | 12.65 |
Highlights
| Market Cap | 886600 K |
| Enterprise Value | 1133.52 M |
| Price/Book TTM | 3.94 |
| Outstanding Share | 68305.14 K |
| Float/ Outstanding Share | 50.21% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.70 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 1.79 |
| Sloan Ratio | -0.070 |
| Peter Lynch Fair Value | 10.57 |
BVS - Growth Highlights
Growth Analysis
Tsr Growth Index - Poor Score of 22.71
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 581848 K | 0.906 % | 15.99 % |
| Gross Profit | 399446 K | 33.29 % | 16.41 % |
| EBITDA | 77382.00 K | 313.01 % | 112.53 % |
| Net Profit | 54464.00 K | 146.27 % | 974.24 % |
| EPS | 0.782 | 143.88 % | NA |
BVS - Stability Highlights
Stability Analysis
Company financial liquidity has improved
Tsr Stability Index - Poor Score of 32.81
Company has high debt burden
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 1.62 | -28.61 % | 1.11 |
| Cash Ratio | 0.319 | 61.65 % | |
| Quick Ratio | 1.19 | 36.54 % | 1.17 |
| Shareholders Equity | 26.93 | 32.53 % | |
| Debt to EBITDA | 2.82 | 141.71 % |
Historical Valuation Ratios of Bioventus Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Bioventus Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Bioventus Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Bioventus Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)